BioInvent International AB (publ) (STO:BINV)
Sweden flag Sweden · Delayed Price · Currency is SEK
22.60
+0.40 (1.80%)
Jul 24, 2026, 5:29 PM CET

STO:BINV Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-350.67-351.68-471.06-369.94-50.92-278.35
Depreciation & Amortization
19.6219.8719.316.7614.7214.61
Other Adjustments
31.534.4263.7221.641.750.87
Changes in Other Operating Activities
38.9949.637.57-10.15-6.7817.03
Operating Cash Flow
-260.57-247.76-380.47-341.69-41.23-245.84
Capital Expenditures
-5.12-7.26-10.03-13.3-12.38-13.26
Other Investing Activities
164.76187.39574.3872.99-616.47-454.28
Investing Cash Flow
159.64180.13564.3559.68-628.85-467.54
Long-Term Debt Repaid
-9.03-8.99-8.46-7.82-6.36-5.92
Net Long-Term Debt Issued (Repaid)
-9.03-8.99-8.46-7.82-6.36-5.92
Issuance of Common Stock
---30.96279.85900.79
Net Common Stock Issued (Repurchased)
---30.96279.85900.79
Financing Cash Flow
-9.03-8.99-8.4623.14273.49894.87
Net Cash Flow
-109.97-76.61175.42-258.87-396.59181.49
Free Cash Flow
-265.69-255.02-390.5-355-53.6-259.1
FCF Margin
-121.96%-112.59%-873.88%-496.77%-16.44%-1336.68%
Free Cash Flow Per Share
-4.03-3.88-5.93-5.40-0.87-4.78
Levered Free Cash Flow
-291-279.6-420.99-344.82-53.29-265.99
Unlevered Free Cash Flow
-296.74-289.02-454.07-376.41-55.35-259.97